Nora Henrikson, PhD, MPH
"I believe that our members are the key to helping us know how to deliver the best care possible."
Nora Henrikson, PhD, MPH
Associate Investigator, Kaiser Permanente Washington Health Research Institute
Associate Professor, Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science
Affiliate Associate Professor, University of Washington School of Public Health, Department of Health Systems and Population Health, and Institute for Public Health Genetics
Biography
Nora Henrikson (she/her) is an associate investigator at Kaiser Permanente Washington Health Research Institute. She leads a research portfolio focused on interventions to improve cancer care delivery, health equity, and patient outcomes.
Her current research explores methods for improving risk notification and cascading genetic testing for family members of people with hereditary cancers as well as interventions to mitigate cancer-related financial hardship. Dr. Henrikson also leads systematic evidence reviews on cancer screening and behavioral counseling with the Kaiser Permanente Evidence-based Practice Center.
Dr. Henrikson holds affiliate faculty appointments at the University of Washington School of Public Health in the Department of Health Systems and Population Health, and the Institute for Public Health Genetics. She is also an associate professor at the Bernard J. Tyson Kaiser Permanente School of Medicine.
She has a PhD from the University of Washington School of Public Health’s Institute for Public Health Genetics, an MPH from the University of North Carolina at Chapel Hill, and a BA (sociology) from Lehigh University.
RESEARCH INTERESTS AND EXPERIENCE
-
Cancer
Genetic testing for cancer risk, cancer-related financial hardship
-
Social Determinants of Health
Financial hardship, health equity
-
Health Services & Economics
Quantitative, qualitative, and mixed methods; intervention design; implementation science
-
Preventive Medicine
-
Evidence-Based Practice
Systematic review and evidence synthesis; epidemiology
-
Public Health Genetics
Social, ethical, and policy implications of genomics and precision health
Recent publications
Henninger ML, Mcmullen CK, Firemark AJ, Naleway AL, Henrikson NB, Turcotte JA. User-centered design for developing interventions to improve clinician recommendation of human papillomavirus vaccination. Perm J. 2017;21. doi: 10.7812/TPP/16-191. PubMed
Naber SK, Kuntz KM, Henrikson NB, Williams MS, Calonge N, Goddard KAB, Zallen DT, Ganiats TG, Webber EM, Janssens ACJW, van Ballegooijen M, Zauber AG, Lansdorp-Vogelaar I. Cost effectiveness of age-specific screening intervals for people with family histories of colorectal cancer. Gastroenterology. 2018 Jan;154(1):105-116.e20. doi: 10.1053/j.gastro.2017.09.021. Epub 2017 Sep 28. PubMed
Henrikson NB, Chang E, Ulrich K, King D, Anderson ML. Communication with physicians about health care costs: survey of an insured population. Perm J. 2017;21. doi: 10.7812/TPP/16-070. PubMed
Henrikson NB, Anderson ML, Opel DJ, Dunn J, Marcuse EK, Grossman DC. Longitudinal trends in vaccine hesitancy in a cohort of mothers surveyed in Washington state, 2013-2015. Public Health Rep. 2017 Jan 1:33354917711175. doi: 10.1177/0033354917711175. [Epub ahead of print]. PubMed
Henrikson NB, Tuzzio L, Gilkey MB, McRee AL. "You're never really off time": healthcare providers' interpretations of optimal timing for HPV vaccination. Prev Med Rep.doi:10.1016/j.pmedr.2016.05.002. [Epub ahead of print]. PubMed
Parchman ML, Henrikson NB, Blasi PR, Buist DS, Penfold R, Austin B, Ganos EH. Taking action on overuse: creating the culture for change. Healthc (Amst). 2016 Nov 10. pii: S2213-0764(16)30167-1. doi: 10.1016/j.hjdsi.2016.10.005. [Epub ahead of print]. PubMed
Henrikson NB, Lau RW, Tuzzio L, Christianson M, Phan TH, Chen E. Treatment prices at the point of care in a clinical oncology service: pilot project. J Oncol Pract. 2016 Oct;12(10):e957-e963. PubMed
Lozano P, Henrikson NB, Morrison CC, Dunn J, Nguyen M, Blasi PR, Whitlock EP. Lipid screening in childhood and adolescence for detection of multifactorial dyslipidemia: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016 Aug 9;316(6):634-44. doi: 10.1001/jama.2016.6423. PubMed
Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock EP. Lipid screening in childhood and adolescence for detection of familial hypercholesterolemia: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016 Aug 9;316(6):645-55. doi: 10.1001/jama.2016.6176. PubMed
Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Blasi PR. Screening for skin cancer in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA.2016;316(4):436-447. doi:10.1001/jama.2016.5415. PubMed
Healthy findings blog
How do you make sense of a mountain of evidence?
KPWHRI researchers answer questions about systematic reviews and their impact on health care guidelines.
HCSRN conference
Researchers present, connect at annual conference
The HCSRN conference is a venue for collaborative work to improve health and health care.
profile
Why does Nora Henrikson study patients’ cost of treatment?
Dr. Henrikson’s Annals of Internal Medicine study describes 3 kinds of cost concerns that can affect cancer care.
video
Discussing patients’ concerns about cost of care
Nora Henrikson discusses her latest research published in the Annals of Internal Medicine in May 2019. (Vimeo, 3:50)
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.